BE719631A - - Google Patents

Info

Publication number
BE719631A
BE719631A BE719631DA BE719631A BE 719631 A BE719631 A BE 719631A BE 719631D A BE719631D A BE 719631DA BE 719631 A BE719631 A BE 719631A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE719631A publication Critical patent/BE719631A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE719631D 1968-02-09 1968-08-16 BE719631A (mo)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH197668A CH498122A (de) 1968-02-09 1968-02-09 Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates

Publications (1)

Publication Number Publication Date
BE719631A true BE719631A (mo) 1969-02-17

Family

ID=4223010

Family Applications (1)

Application Number Title Priority Date Filing Date
BE719631D BE719631A (mo) 1968-02-09 1968-08-16

Country Status (10)

Country Link
AT (1) AT277257B (mo)
BE (1) BE719631A (mo)
CH (1) CH498122A (mo)
DE (1) DE1795132A1 (mo)
DK (1) DK123526B (mo)
ES (1) ES357247A1 (mo)
FR (1) FR1598948A (mo)
GB (1) GB1225053A (mo)
IL (1) IL30458A (mo)
NL (1) NL6811311A (mo)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2171879A1 (en) * 1972-02-14 1973-09-28 Pennwalt Corp 1,2,4,5-tetrahydro-3h-3-benzazepines - analgesics narcotic antagonists, antihistamines etc
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
JP4782003B2 (ja) 2003-06-17 2011-09-28 アリーナ ファーマシューティカルズ, インコーポレイテッド 5ht2cレセプター関連疾患の処置に有用なベンズアゼピン誘導体
DK2332921T3 (en) 2003-06-17 2016-05-09 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3benzazepine hydrochloride
TW200510324A (en) * 2003-08-11 2005-03-16 Lilly Co Eli 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
RS50996B (sr) 2004-12-21 2010-10-31 Arena Pharmaceuticals Inc. Kristalni oblici (r)-8-hloro-1-metil-2,3,4,5-tetrahidro-1h-benzazepin hlorhidrat
KR101519441B1 (ko) 2004-12-23 2015-05-12 아레나 파마슈티칼스, 인크. 5ht2c 수용체 조정물질 조성물 및 그의 사용 방법
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
WO2009111004A1 (en) 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
SG10201506865WA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
SG10201506874UA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Also Published As

Publication number Publication date
IL30458A (en) 1972-03-28
GB1225053A (en) 1971-03-17
AT277257B (de) 1969-12-29
ES357247A1 (es) 1970-03-01
FR1598948A (mo) 1970-07-15
DE1795132A1 (de) 1972-01-05
DK123526B (da) 1972-07-03
CH498122A (de) 1970-10-31
IL30458A0 (en) 1968-09-26
NL6811311A (mo) 1969-08-12

Similar Documents

Publication Publication Date Title
AU1946070A (mo)
AU428130B2 (mo)
AU2374870A (mo)
AU5184069A (mo)
AU6168869A (mo)
AU6171569A (mo)
AU429879B2 (mo)
AU416157B2 (mo)
AU2581067A (mo)
AU4811568A (mo)
AU421558B1 (mo)
AU4744468A (mo)
AU3789668A (mo)
AU3224368A (mo)
AU2580267A (mo)
AU479393A (mo)
BE642636A (mo)
AU4558658A (mo)
AU463027A (mo)
AU4464266A (mo)
BE709274A (mo)
AU479894A (mo)
AU4270368A (mo)
AU4224469A (mo)
AU3083868A (mo)